AbbVie will also acquire Nimble's peptide synthesis platform, which is used to discover and optimize oral peptide therapeutics. Roche further taps drug discovery spinout's Nimble tech in $1.1B ...
The molecular machines that Pistofidis and Schmeing studied are called nonribosomal peptide synthetases, or NRPSs. They build some of the most important compounds in current health care and ...
The Bureau of Industry and Security is placing new export controls on certain toxins, chemicals and other items that can be used to make bioweapons as part of a final rule to align its restrictions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback